Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir

doi:10.3748/wjg.v24.i40.4554

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 40

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6690)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

435

WORD

224

HTML

3315

Figures (1-7)

279

Tables (1-1)

346

Sum=4599

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

770

Download

1321

Sum=2091

Oct 28, 2018 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Oct 28, 2018; 24(40): 4554-4564
Published online Oct 28, 2018. doi: 10.3748/wjg.v24.i40.4554

Full Size Figure Download Figure

Figure 2 Flow cytometry results. A: Isolation of human peripheral blood natural killer (NK) cells and subsets; B: The expression of NKp46, NKp30, NKG2D, CD94, NKG2C and NKG2A during and after the end of direct-acting antivirals (DAAs) treatment; C: The expression of Granzyme B, IFN-γ and perforin during and after the end of DAAs treatment. NK: Natural killer; IFN: Interferon; DAAs: Direct-acting antivirals.

Citation: Wang XX, Luo BF, Jiang HJ, Cong X, Jin Q, Ma DL, Wei L, Feng B. Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir. World J Gastroenterol 2018; 24(40): 4554-4564
URL: https://www.wjgnet.com/1007-9327/full/v24/i40/4554.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i40.4554